Small cell lung cancer (SCLC ... and becoming non-neuroendocrine (non-NE) cancer cells. They also observed that together, these cancer cells collaborated to promote tumor development.

Scientists found that aggressive lung cancer cells create their own electrical network, helping them spread. This unique ...

M: Metastasis; N: Node; T: Tumor. Data from [21]. Neuroendocrine tumors have demonstrated an increase in incidence and prevalence over the past decades, partly due to increased awareness ...

DDR status affects tumor evolution and immune evasion, influencing immunotherapy response. Larger clinical trials are necessary to confirm these findings and improve SCLC treatment strategies.

Olvi-Vec showed a 71% disease control rate in phase 1b trial for advanced SCLC, with significant tumor reductions in some patients. The safety profile of Olvi-Vec was manageable, with mild to moderate ...

She had been diagnosed as having metastatic pulmonary neuroendocrine tumor. The patient's medical and family history was unremarkable; she had, however, smoked more than 20 cigarettes per day for ...